AI assistant
Orchid Pharma Limited — Call Transcript 2025
May 26, 2025
60526_rns_2025-05-26_57d7026c-f135-42cb-b85f-8f40afb7a5bc.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [557 x 64] intentionally omitted <==
May 26, 2025
National Stock Exchange of India Limited, BSE Limited Exchange Plaza, Bandra Kurla Complex Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai-400051
Symbol: ORCHPHARMA Scrip Code: 524372
Ref: (i) Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (ii) SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024
Sub : Audio Recording of the Analysts/Investors Earnings Call - Orchid Pharma Limited (“the Company”)
Dear Sir/Madam,
With reference to the above captioned subject and pursuant to Regulation 30, Subpara 15 of Para A Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 and in continuation to earlier intimations dated May 20, 2025 for intimation of Analysts/ Investor Earnings call, we would like to inform you that the Audio Recording of the Analysts/Investors Earnings Call held today i.e. May 26, 2025 at 04:30 P.M. (IST) to discuss the Audited Financial Results (Standalone and Consolidated) for the Quarter- IV and Financial Year ended March 31, 2025 has been uploaded on the website of the Company. Please find below the link to the Audio Recording of the same:
Link: https://www.orchidpharma.com/downloads/audio/10032630.mp3
This is to confirm that the Analysts/Investors Earnings call was held through Audio Conference call and no Video Recording is available for same.
You are requested to take the above on your record.
Thanking You,
For Orchid Pharma Limited
Digitally signed by KAPIL DAYYA DN: c=IN, o=Person, ou=Others, postalCode=201102, l=Ghaziabad, st=Uttar Pradesh, street=238, NAIPURA LONI, GHAZIABAD LONI, title=2894, 2.5.4.20=ab829c22de1effbdfc0b22c1656149c2ef30e 6aef4e71d29529c889286e22c52, serialNumber=e27acd3bad231a5f6fbc79a89feead64 2f7b38cfefea6c40cc3f8a9ba46b16ed, email=[email protected], cn=KAPIL DAYYA Date: 2025.05.26 21:35:36 +05'30'
DN: c=IN, o=Person, ou=Others, postalCode=201102, l=Ghaziabad, st=Uttar Pradesh, street=238, NAIPURA KAPIL LONI, GHAZIABAD LONI, title=2894, 2.5.4.20=ab829c22de1effbdfc0b22c1656149c2ef30e 6aef4e71d29529c889286e22c52, serialNumber=e27acd3bad231a5f6fbc79a89feead64 2f7b38cfefea6c40cc3f8a9ba46b16ed, DAYYA email=[email protected], cn=KAPIL DAYYA Kapil Dayya Date: 2025.05.26 21:35:36 +05'30' Company Secretary & Compliance Officer Mem. No.- F10698
==> picture [552 x 13] intentionally omitted <==
Orchid Pharma Limited Regd. Office: Plot Nos. 121-128, 128A-133, 138-151, 159-164, SIDCO Industrial Estate, Alathur, Chengalpattu Dist.- 603110, Tamil Nadu, India